Mainz Biomed B.V. Made Headway
Tue, Jan 18, 2022 at 05:30 PM
Mainz Biomed B.V. (MYNZ:NASDAQ) jumped higher at $26.69, representing a gain of 27.9%. On Fri, Jan 14, 2022, MYNZ:NASDAQ hit a New 2-Week High of $20.87. The stock appeared on our News Catalysts scanner on Wed, Jan 12, 2022 at 03:26 AM in the 'MISCELLANEOUS' category. From Mon, Jan 03, 2022, the stock recorded 55.56% Up Days and 50.00% Green Days
About Mainz Biomed B.V. (MYNZ:NASDAQ)
Mainz Biomed BV is engaged in developing molecular genetic diagnostic solutions for life-threatening conditions.
Top 10 Gainers:
- Brickell Biotech, Inc. (BBI:NASDAQ), 58.58%
- DatChat Inc. (DATS:NASDAQ), 38.75%
- Indonesia Energy Corporation Limited (INDO:NYSEMKT), 31.1%
- NeuroMetrix, Inc. (NURO:NASDAQ), 29.47%
- Mainz Biomed B.V. (MYNZ:NASDAQ), 27.89%
- Vinco Ventures Inc. (BBIG:NASDAQ), 27.52%
- Activision Blizzard, Inc. (ATVI:NASDAQ), 25.88%
- Immuron Limited (IMRN:NASDAQ), 24.78%
- G Medical Innovations Holdings Ltd. (GMVD:NASDAQ), 20.29%
- Integrated Media Technology Limited (IMTE:NASDAQ), 19.95%